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Abstract
Background: Chronic diarrhea in patients treated with immunosuppressive agents or suffering from
immunosuppressive disease can represent a diagnostic and therapeutic challenge to the clinician. Norovirus
infection, a major cause of acute epidemic diarrhea, has been described as a cause of chronic diarrhea in patients
who are immunosuppressed, including transplant recipients and the very young.
Case presentations: We describe two patients, a 64 year-old man and a 59 year-old woman, both suffering from
chronic lymphocytic leukemia and hypogammaglobulinemia, who developed chronic diarrhea resistant to therapy.
In both cases, after months of symptoms, persistent norovirus infection–documented by repeatedly-positive high-
sensitivity stool enzyme immunoassay–was found to be the cause. Both patients died with active diarrheal
symptoms.
Conclusions: We describe the first cases of advanced chronic lymphocytic leukemia to suffer from chronic
symptomatic norovirus infection. Clinicians caring for such patients, particularly those with concomitant
hypogammaglobulinema, who have chronic unexplained diarrhea, should consider norovirus infection in the
differential diagnosis.
Background
Norovirus is the major cause of epidemic viral gastroenter-
itis worldwide, affecting all age groups [1]. The disease is
generally acute and self limited. However, there have been
reported cases of chronic norovirus infections, especially
in the setting of long-term immunosuppression, such as
organ transplantation [2,3]. These infections can be debili-
tating, causing severe wasting and malnutrition, and can
be confused with graft-versus-host reactions. Chronic lym-
phocytic leukemia (CLL) can be associated with defective
immunity, leading to severe, recurrent infections [4,5]. We
report two patients with CLL and hypogammaglobuline-
mia affected by chronic norovirus infection.
Case Presentation
First Case
The first patient, a 64 year old man diagnosed with CLL
noted to be hypogammaglobulinemic since 2006, began
having profuse, watery, non-bloody diarrhea starting in
2007, presenting initially with nausea and fever (100.5 F)
which persisted for a week. The patient did not report
exposure to others with diarrhea. He experienced up to
12 bowel movements daily, and was treated with intra-
venous immunoglobulin, octreotide, nitazoxanide, mesa-
lamine and antimotility agents (including loperamide
and diphenoxylate/atropine) without symptomatic
improvement. Total parenteral nutrition (TPN) was
initiated and continued for almost two years; a period of
fasting while on TPN did not result in a reduction in
stool frequency. An extensive gastroenterologic evalua-
tion, including stool for leukocytes (none seen), fecal fat
measurement (normal), gliadin antibody assay (negative),
endoscopy, capsule endoscopy, and colonoscopy were
performed; colonic biopsies demonstrated focal active
colitis with an area of detached mucus and neutrophilic
exudate but with preserved villi, while duodenal biopsy
yielded normal mucosa. Extensive stool evaluation for
non-viral pathogens (including C. difficle, Camplyobac-
ter spp., Salmonella spp., and Yersinia; cryptosporidium,
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lamblia [including antigen assay] and ova and parasite
evaluation) and hormonal assays (gastrin, vasoactive
intestinal polypeptide, and calcitonin) failed to yield a
diagnosis. After a year of chronic diarrhea, norovirus
was identified in stool by enzyme immunoassay (EIA;
RIDASCREEN
® norovirus enzyme immunoassay; R-Bio-
pharm, Dusseldorf, Germany) [6] in July 2008, both at
our institution and at another teaching facility. His
immunoglobulins at that time were profoundly low (IgG
141 mg/dl [normal: 700-1600 mg/dl]; IgA 11 mg/dl
[normal: 70-400 mg/dl]; IgM 6 mg/dl [normal 40-230
mg/dl]). Stool studies for norovirus remained positive in
September and December 2008, and again in February
2009. The patient expired in February 2009 from pneu-
monia and septic shock after receiving one cycle of
rituximab, cyclophosphamide, vincristine and predni-
sone. As members of his family had not contracted diar-
rhea during his long undiagnosed course, no effort was
made to isolate the patient but handwashing and atten-
tion to hygiene was advised.
Second Case
The second patient, a 59 year old woman diagnosed
with CLL in 1999 was initially found to be hypogamma-
globulinemic in 2006 without prior history of recurrent
infection. She had received multiple chemotherapeutic
interventions over the years; her most recent treatment
regimen consisted of rituximab and corticosteroids. The
patient commenced intravenous immunoglobulin ther-
apy in January 2009, following recurrent hospitalizations
for pneumonia (at that time IgG 512 mg/dl, IgA < 7
mg/dl, IgM 30 mg/dl). In February 2009, after members
of her immediate family experienced an undiagnosed,
self-limited diarrheal illness accompanied by fever and
vomiting, the patient developed bloating and daily
watery, non-bloody and non-purulent diarrhea that was
predominantly nocturnal (with 3-4 episodes nightly),
and weight loss. Her initial presentation was associated
with fever, but this abated after 10 days; she did not
experience nausea or vomiting. Supportive measures
(antimotility agents as noted above, active cultures,
avoidance of lactose containing products, cholestyra-
mine, and octreotide) were ineffective, and she began to
require frequent infusions of intravenous fluids to com-
bat dehydration. Infectious workup of her diarrhea
revealed stool positive for the norovirus antigen (by
EIA) on three occasions: March, May, and September
2009. Further gastroenterological evaluation, including
endoscopy/colonoscopy, and stool evaluation for other
infectious agents (culture, ova and parasite evaluation,
trichrome stain, cryptosporidium and microsporidium
stains, and Giardia lamblia antigen assay) failed to
reveal another cause for her diarrhea. Duodenal biopsy
in April 2009 revealed mild, active duodenitis, but no
other specific diagnosis; random colonic biopsy yielded
normal colonic mucosa. The patient had continuing
symptoms for 11 months, had lost 10 kg despite TPN
and continued to have problems with malnutrition.
Diarrhea continued despite a period of fasting while on
TPN. No specific treatment was offered to control the
norovirus; the patient ultimately developed respiratory
failure due to bilateral lobar pneumonia and died in
October 2010. As her family had recovered from their
diarrheal illness and had not had a recurrence during
her prolonged course, no attempt to isolate the patient
was made, but advice on handwashing and hygiene was
given.
Discussion
Chronic diarrhea, defined as symptoms persisting for 2
or more weeks, has a myriad of causes including infec-
tion, medication, malignancy, and inflammatory condi-
tions. Norovirus, a calicivirus, is associated with acute
gastroenteritis in humans, and is spread through the
fecal-oral route, either by consumption of contaminated
food or water or by direct person-person spread [1].
After an incubation period of 24 to 48 hours, patients
often present with acute onset vomiting, watery non-
bloody diarrhea with abdominal cramps, and nausea.
Dehydration is the most common complication, espe-
cially in children and the elderly. Symptoms of this
infection usually persist 24 to 60 hours, and the disease
is almost always self-limited. However, hospital patient
populations have been described with longer mean dura-
tion of illness, lasting 80 hours [1,3]. In the elderly,
while acute symptoms abate after three to four days,
other symptoms such as thirst, anorexia, lethargy, and
vertigo can persist for up to 19 days, leading to delayed
recovery and other complications [7,8]. The diagnosis is
usually made with reverse transcriptase-polymerase
chain reaction (RT-PCR) or EIA to detect the presence
of norovirus in stool or emesis samples. The virus can
be found in stool samples as late as 3 to 8 weeks after
recovery in community based outbreaks in otherwise
healthy individuals, with increasing age and children less
than 2 years of age associated with long term shedding;
however, no significant increase in symptoms has been
found as viral concentrations diminish over time [8-11].
Gastrointestinal symptoms resulting from a variety of
viral, bacterial, or parasitic pathogens, or from drug ther-
apy or graft-versus-host disease, are common causes of
morbidity and mortality in immunocompromised hosts,
particularly those with solid organ transplantation requir-
ing chronic immunosuppressant medication and patients
undergoing systemic chemotherapy, or those infected
with human immunodeficiency virus (see Table 1) [12].
Hypogammaglobulinemia in particular appears to be a
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tion in organ transplant patients, leading to severe gas-
trointestinal disease [12].
More prolonged shedding and higher concentrations
of norovirus have also been described in immunocom-
promised hosts, including congenital conditions, such as
severe combined immunodeficiency and T-cell immuno-
deficiency, and acquired immunodeficiency, such as the
setting of transplantation and patients with solid tumors
receiving cytotoxic chemotherapy [1-3,12-14]. One study
of pediatric oncology patients described norovirus shed-
ding for durations exceeding 100 days–one patient had
detectable norovirus detected for 420 days–leading to
severe weight loss and growth retardation [13]. The case
of a patient infected with human immunodeficiency
virus (HIV) experiencing chronic norovirus infection
and persistent, voluminous diarrhea treated with intra-
venous immunoglobulin was reported recently; no sig-
nificant improvement was seen, although the patient
was not noted to be hypogammaglobulinemic [14].
Norovirus appears to be a rare cause of chronic diar-
rhea, and its diagnosis is reliant on stool testing for pre-
sence of the virus, as characteristic pathological findings,
simpler stool culture or routinely-applied clinical screen-
ing assays are lacking; consequently, it is conceivable
that chronic norovirus-associated diarrhea may be more
common than currently appreciated in patients with a
variety of immunodeficiency disorders. Additionally, spe-
cific and effective therapies are not currently available
for this condition. In our two cases intravenous gamma
globulin did not result in amelioration of symptoms or
eradication of the virus.
Patients with CLL have a number of immune system
defects that evolve over time, including disordered B-cell
function with decreased production of normal B-cells
and abnormal production of immune globulins [15], sup-
pressed T-cell function [16], and ultimately hypogamma-
globulinemia and neutropenia in advanced cases [17].
Which defect, or combination of defects, is crucial to the
development of persistent norovirus infection is
Table 1 Causes of chronic diarrhea in patients with immunodeficiency [18,19]
Infectious Causes Bacteria Escherichia coli
Salmonella
Shigella
Campylobacter jejuni
Clostridium difficile
Mycoabacterium tuberculosis
Mycobacterium avium complex (MAC)
Parasites Cryptosporidium
Microsporidium
Isospora Belli
Giardia lamblia
Entamoeba histolytica
Viral Infections Cytomegalovirus
Herpes virus
HIV (AIDS enteropathy)
Rotavirus
Astrovirus
Norovirus
Fungus Candida
Other Causes Invasive bacterial enteritis
Non-Infectious Causes Treatment-related Radiation enteritis–acute/chronic
Graft-versus-host disease
Chemotherapy–fluoropyrimidines, irinotecan
Other medication side-effects
Malabsorption Small bowel bacterial overgrowth
Lymphoma
Kaposi sarcoma
Pancreatic insufficiency–cytomegalovirus, MAC, medications
Other Causes Irritable bowel syndrome
Functional disorders
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nemia was a common finding; the first case had not yet
been treated with chemotherapy or anti CD-20 monoclo-
nal antibody therapy at the time of development of noro-
virus-associated diarrhea.
Conclusions
While CLL associated with hypogammaglobulinemia is
commonly linked to recurring infection, [5] our litera-
ture search failed to find other reports of patients with
CLL suffering from persistent diarrhea as a result of
chronic norovirus infection. Enteric viral infections,
including norovirus, should be considered in the differ-
ential diagnosis of severe, persistent diarrhea in all
immunocompromised patients–including CLL–that may
result in severe morbidity and mortality in those
affected.
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